References
- World Health Organization. COVID-19 Public Health Emergency of International Concern (PHEIC) Global Research and Innovation Forum. World Health Organization; 2020.
- Oliver SE, Gargano JW, Marin M, et al. The advisory committee on immunization practices’ interim recommendation for use of Pfizer-BioNTech Covid-19 vaccine - United States, December 2020. MMWR Morb Mortal Wkly Rep. 2020;69(50):1922–1924. doi:10.15585/mmwr.mm6950e2
- Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603–2615. doi:10.1056/NEJMoa2034577
- Lehmann A, Matoba A. Reactivation of herpes zoster stromal keratitis after HZ/su adjuvanted herpes zoster subunit vaccine. Ophthalmology. 2018;125(11):1682. doi:10.1016/j.ophtha.2018.08.030
- Chen J, Dai L, Barrett L, et al. SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus. bioRxiv. 2020;4(1):1–6.
- Torres HA, Hosry J, Mahale P, et al. Hepatitis C virus reactivation in patients receiving cancer treatment: a prospective observational study. Hepatology. 2018;67(1):36–47. doi:10.1002/hep.29344
- Patterson AT. JAAD game changers: risk for hepatitis B and C virus reactivation in patients with psoriasis on biologic therapies: a retrospective cohort study and systematic review of the literature. J Am Acad Dermatol. 2020;82(2):532. doi:10.1016/j.jaad.2019.09.055